BOT:ASX
Botanix Pharmaceuticals Ltd
0,010 AUD
0,00%
(0,00) 1D
19 ნოე, 16:10:03 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
27,63 მლნ.
Avg. vol.
11,81 მლნ.
Volume
2,69 მლნ.
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 მლრდ.
No. of employees
11
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
27,63 მლნ.
Avg. vol.
11,81 მლნ.
Volume
2,69 მლნ.
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 მლრდ.
No. of employees
11
News stories
From web sources and news partners
BigGo Finance
·
43 წუთის წინ
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
Stocktwits
·
1 საათის წინ
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
BeInCrypto
·
2 საათის წინ
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
Traders Union
·
3 საათის წინ
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com